Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-16-127436

Options or other derivatives

  • S.V.P., General Counsel acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Ozeroff Christopher David S.V.P., General Counsel 2016-06-09 Grant or award · Stock Option (right to buy) +14,800 14,800 D
Ozeroff Christopher David S.V.P., General Counsel 2016-06-09 Grant or award · Stock Option (right to buy) +30,200 30,200 D
Loading xslF345X03/doc4.xml…